Show simple item record

Asciminib as a new option in the treatment of chronic myeloid leukemia

dc.contributor.authorIbis, Betul
dc.contributor.authorEŞKAZAN, AHMET EMRE
dc.contributor.authorTiribelli, Mario
dc.date.accessioned2021-12-10T11:59:11Z
dc.date.available2021-12-10T11:59:11Z
dc.identifier.citationIbis B., Tiribelli M., EŞKAZAN A. E. , "Asciminib as a new option in the treatment of chronic myeloid leukemia", FUTURE ONCOLOGY, 2021
dc.identifier.issn1479-6694
dc.identifier.othervv_1032021
dc.identifier.otherav_a15dd958-72b4-48d4-82ec-247bc5fe5d70
dc.identifier.urihttp://hdl.handle.net/20.500.12627/173022
dc.identifier.urihttps://doi.org/10.2217/fon-2021-1174
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectOncology
dc.subjectHealth Sciences
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleAsciminib as a new option in the treatment of chronic myeloid leukemia
dc.typeMakale
dc.relation.journalFUTURE ONCOLOGY
dc.contributor.departmentİstanbul Üniversitesi-Cerrahpaşa , ,
dc.contributor.firstauthorID2772190


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record